Clinical Trial Update: A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 randomized trial evaluating spermidine to prevent radiation-induced xerostomia in patients with head and neck cancers, including nasopharyngeal carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Nasopharyngeal Carcinoma

Drugs mentioned

• Spermidine (spermidine)

Snippet

Sponsor: West China Hospital | Conditions: Radiation-induced Xerostomia | Phase 1, Phase 2 | Status: RECRUITING